RNS Number : 5709E Spire Healthcare Group PLC 10 April 2025 10 April 2025 Spire Healthcare Group plc (the Company) Exercise of Executive Share Plan awards On 7 April 2025, the Executive Directors of the Company, exercised vested Executive Share Plan awards as follows: (1)  Justin Ash exercised both his: · Long Term Incentive Plan award in the Company that were granted on 6 April 2020 (the 2020 LTIP award). 2020 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2022 Annual Report and Accounts. On vesting in April 2023, the 2020 LTIP awards were subject to a further two-year holding period which ended in April 2025; and · Deferred Share Bonus Plan awards that were granted on 14 March 2022 (the 2022 DSBP award). 2022 DSBP awards were subject to a three-year holding period which ended on the third anniversary of the award being made; and (2)  Harbant Samra exercised his Long Term Incentive Plan award in the Company that were granted on 14 March 2022 (the 2022 LTIP award). 2022 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2024 Annual Report and Accounts. Following the exercise by the Directors of these awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows: Following the transactions, Justin Ash holds 1,298,641 ordinary shares in the Company. Following the transactions, Harbant Samra holds 53,259 ordinary shares in the Company. Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHBSGDSCBBDGUG